Clinical Trial Update: Buprenorphine and Integrated HIV Care [Phase 4]

View source ↗

Summary

Phase 4 trial update on buprenorphine with integrated HIV care for substance-related disorders and HIV/AIDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug Addiction
• HIV Infection
• HIV Infections
• Human Immunodeficiency Virus
• Substance-related Disorders

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Yale University | Conditions: Substance-related Disorders, Drug Addiction | Phase 4 | Status: COMPLETED